Intestinal Research

Real-time data monitoring for ulcerative colitis: patient perception and qualitative analysis: Alissa Walsh, Lawrence Matini, Christopher Hinds, Vanashree Sexton, Oliver Brain, Satish Keshav, John Geddes, Guy Goodwin, Gary Collins, Simon Travis, Michele Peters; Received January 4, 2019 Accepted April 30, 2019; DOI: https://doi.org/10.5217/ir.2018.00173 [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF

Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn’s disease in Asia: Choon Jin Ooi, Ida Hilmi, Rupa Banerjee, Sai Wei Chuah, Siew Chien Ng, Shu Chen Wei, Govind K Makharia, Pises Pisespongsa, Min Hu Chen, Zhi Hua Ran, Byong Duk Ye, Dong Il Park, Khoon Lin Ling, David Ong, Vineet Ahuja, Khean Lee Goh, Jose Sollano, Wee Chian Lim, Wai Keung Leung, Raja Affendi Raja Ali, Deng Chyang Wu, Evan Ong, Nazri Mustaffa, Julajak Limsrivilai, Tadakazu Hisamatsu, Suk Kyun Yang, Qin Ouyang, Richard Geary, Janaka H De Silva, Rungsun Rerknimitr, Marcellus Simadibrata, Murdani Abdullah, Rupert WL Leong, the Asia Pacific Association of Gastroenterology (APAGE) Working Group on Inflammatory Bowel Disease and Asian Organization for Crohn’s and Colitis; Received March 20, 2019 Accepted April 15, 2019; DOI: https://doi.org/10.5217/ir.2019.00026 [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF

Remission of diffuse ulcerative duodenitis in a patient with ulcerative colitis after infliximab therapy: a case study and review of the literature: Yong-Sung Choi, Jong Kyu Kim, Wan Jung Kim, Mi-Jung Kim; Intest Res. 2019;17(2):273-277. Published online February 12, 2019; DOI: https://doi.org/10.5217/ir.2018.00122; Full text PubReader ePub Crossref - TDM PDF

Efficacy and safety of abrilumab, an α4β7 integrin inhibitor, in Japanese patients with moderate-to-severe ulcerative colitis: a phase II study: Toshifumi Hibi, Satoshi Motoya, Toshifumi Ashida, Souken Sai, Yukinori Sameshima, Shiro Nakamura, Atsuo Maemoto, Masahiro Nii, Barbara A Sullivan, Robert A. Gasser Jr, Yasuo Suzuki; Received October 12, 2018 Accepted December 27, 2018; DOI: https://doi.org/10.5217/ir.2018.00141 [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF

Adherence to Asacol once daily versus divided regimen for maintenance therapy in ulcerative colitis: a prospective, multicenter, randomized study: Soo-Kyung Park, Sang Hyun Park, Chang Soo Eun, Geom Seog Seo, Jong Pil Im, Tae Oh Kim, Dong-Il Park; Received May 15, 2018 Accepted November 9, 2018; DOI: https://doi.org/10.5217/ir.2018.00064 [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF

Individualized treatment based on CYP3A5 single-nucleotide polymorphisms with tacrolimus in ulcerative colitis: Shinji Okabayashi, Taku Kobayashi, Eiko Saito, Takahiko Toyonaga, Ryo Ozaki, Shintaro Sagami, Masaru Nakano, Junichi Tanaka, Keiji Yagisawa, Satoshi Kuronuma, Osamu Takeuchi, Toshifumi Hibi; Intest Res. 2019;17(2):218-226. Published online February 7, 2019; DOI: https://doi.org/10.5217/ir.2018.00117
Cited By 1; Full text PubReader ePub Crossref - TDM PDF

Hypoalbuminemia as a risk factor for thromboembolic events in inflammatory bowel disease inpatients: Marcello Rabello Imbrizi, Daniela Oliveira Magro, Tirzah de Mendonça Lopes Secundo, Marlone Cunha-Silva, Paulo Gustavo Kotze, Ciro Garcia Montes, Jazon Romilson de Souza Almeida, Virgínia Lúcia Ribeiro Cabral; Intest Res. 2019;17(1):63-69. Published online January 25, 2019; DOI: https://doi.org/10.5217/ir.2018.00077; Full text PubReader ePub Crossref - TDM PDF

Current new challenges in the management of ulcerative colitis: Tomohiro Fukuda, Makoto Naganuma, Takanori Kanai; Intest Res. 2019;17(1):36-44. Published online January 25, 2019; DOI: https://doi.org/10.5217/ir.2018.00126
Cited By 1; Full text PubReader ePub Crossref - TDM PDF

Clinical aspects and treatments for pediatric inflammatory bowel disease: Jin Soo Moon; Intest Res. 2019;17(1):17-23. Published online January 9, 2019; DOI: https://doi.org/10.5217/ir.2018.00139; Full text PubReader ePub Crossref - TDM PDF

The novel latex agglutination turbidimetric immunoassay system for simultaneous measurements of calprotectin and hemoglobin in feces: Sakiko Hiraoka, Shiho Takashima, Toshihiro Inokuchi, Asuka Nakarai, Masahiro Takahara, Keita Harada, Yasuhiro Seki, Katsunori Watanabe, Jun Kato, Hiroyuki Okada; Intest Res. 2019;17(2):202-209. Published online December 14, 2018; DOI: https://doi.org/10.5217/ir.2018.00086
Cited By 1; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Randomized, crossover questionnaire survey of acceptabilities of controlled-release mesalazine tablets and granules in ulcerative colitis patients: Keiji Yagisawa, Taku Kobayashi, Ryo Ozaki, Shinji Okabayashi, Takahiko Toyonaga, Miki Miura, Mari Hayashida, Eiko Saito, Masaru Nakano, Hajime Matsubara, Tadakazu Hisamatsu, Toshifumi Hibi; Intest Res. 2019;17(1):87-93. Published online December 14, 2018; DOI: https://doi.org/10.5217/ir.2018.00078; Full text PubReader ePub Crossref - TDM PDF

Efficacy of fecal microbiota therapy in steroid dependent ulcerative colitis: a real world intention-to-treat analysis: Ajit Sood, Ramit Mahajan, Garima Juyal, Vandana Midha, Charanpreet Singh Grewal, Varun Mehta, Arshdeep Singh, Mohan C Joshi, Vikram Narang, Kirandeep Kaur, Hasrat Sidhu; Intest Res. 2019;17(1):78-86. Published online November 20, 2018; DOI: https://doi.org/10.5217/ir.2018.00089
Cited By 4; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Epidemiological trend in inflammatory bowel disease in Taiwan from 2001 to 2015: a nationwide populationbased study: Hsu-Heng Yen, Meng-Tzu Weng, Chien-Chih Tung, Yu-Ting Wang, Yuan Ting Chang, Chin-Hao Chang, Ming-Jium Shieh, Jau-Min Wong, Shu-Chen Wei; Intest Res. 2019;17(1):54-62. Published online November 20, 2018; DOI: https://doi.org/10.5217/ir.2018.00096
Cited By 1; Full text PubReader ePub Crossref - TDM PDF

Successful transition from pediatric to adult care in inflammatory bowel disease: what is the key?: Jeongseok Kim, Byong Duk Ye; Intest Res. 2019;17(1):24-35. Published online November 12, 2018; DOI: https://doi.org/10.5217/ir.2018.00128; Full text PubReader ePub Crossref - TDM PDF

Consensus recommendations for patient-centered therapy in mild-to-moderate ulcerative colitis: the i Support Therapy–Access to Rapid Treatment (iSTART) approach: Silvio Danese, Rupa Banerjee, JR Fraser Cummings, Iris Dotan, Paulo G Kotze, Rupert Wing Loong Leong, Kristine Paridaens, Laurent Peyrin-Biroulet, Glyn Scott, Gert Van Assche, Jan Wehkamp, Jesús K Yamamoto-Furusho; Intest Res. 2018;16(4):522-528. Published online October 16, 2018; DOI: https://doi.org/10.5217/ir.2018.00073; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Search